Long Wang
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Evaluation of six clinical prognostic scores in NSCLC patients undergoing first line chemoimmunotherapy.
Journal: Frontiers in immunology
Published: August 30, 2025
Prognostic value of the MDACC-NLR score in extensive-stage small-cell lung cancer treated with first-line chemoimmunotherapy.
Journal: Frontiers in immunology
Published: August 07, 2025
Identification of beneficial populations for targeted-immunotherapy combinations: tailoring later-line care for patients with pMMR/MSS metastatic colorectal cancer.
Journal: Frontiers in immunology
Published: July 10, 2024
Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer.
Journal: World journal of gastrointestinal oncology
Published: June 11, 2024
Blood lipid profiles associated with metastatic sites in advanced gastric cancer.
Journal: BMC gastroenterology
Published: May 24, 2024
Microbiome, metabolome, and transcriptome analyses in esophageal squamous cell carcinoma: insights into immune modulation by F. nucleatum.
Journal: Protein & cell
Published: May 07, 2024
CHNet: A multi-task global-local Collaborative Hybrid Network for KRAS mutation status prediction in colorectal cancer.
Journal: Artificial intelligence in medicine
Published: September 25, 2023
PMSG-Net: A priori-guided multilevel graph transformer fusion network for immunotherapy efficacy prediction.
Journal: Computers in biology and medicine
Published: June 08, 2023
Integrating image and gene-data with a semi-supervised attention model for prediction of KRAS gene mutation status in non-small cell lung cancer.
Journal: PloS one
Published: June 05, 2023
Case Report: MSS colorectal extrahepatic (non-liver) metastases as the dominant population for immunotherapy combined with multi-target tyrosine kinase inhibitors.
Journal: Frontiers in oncology
Published: November 22, 2022
Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report.
Journal: Cancer management and research
Published: August 23, 2022
Last Updated: 09/26/2026